The editors of the Nature group of journals have announced that they will extend their policy for disclosing financial ties to include authors of review papers, but they have not gone as far as a group of senior academics and former journal editors would like them to.

Nature journals already publish statements of commercial interest for all primary papers. In the October issue of Nature Neuroscience, the journal's editors write that the journals are widening that policy in response to concerns raised by a review article published last November.

The paper on treatments for mood disorders, by Charles B. Nemeroff and Michael J. Owens of Emory University School of Medicine in Atlanta, included three products to which Nemeroff had significant financial ties.

In February of this year, Robert T. Rubin of the Center for Neurosciences Research, Allegheny General Hospital, and Bernard J. Carroll of the Pacific Behavioral Research Foundation,...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?